Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
BDX

Becton Dickinson and Co

BDX

232.29USD-1.25 (-0.54%)Market Closed
Watchlist

Market Summary

USD232.29-1.25
Market Closed
-0.54%

BDX Alerts

  • 1 major insider sales recently.
  • Big fall in earnings (Y/Y)

BDX Stock Price

View Fullscreen

BDX RSI Chart

BDX Valuation

Market Cap

71.3B

Price/Earnings (Trailing)

44.09

Price/Sales (Trailing)

3.79

EV/EBITDA

15.66

Price/Free Cashflow

72.01

BDX Price/Sales (Trailing)

BDX Profitability

EBT Margin

9.46%

Return on Equity

6.42%

Return on Assets

3.14%

Free Cashflow Yield

1.39%

BDX Fundamentals

BDX Revenue

Revenue (TTM)

19.4B

Revenue Y/Y

6.85%

Revenue Q/Q

4.28%

BDX Earnings

Earnings (TTM)

1.5B

Earnings Y/Y

-62.5%

Earnings Q/Q

-73.46%

Price Action

Last 7 days

-1.1%

Last 30 days

-8.8%

Last 90 days

-12.5%

Trailing 12 Months

-4.5%

How does BDX drawdown profile look like?

BDX Financial Health

Current Ratio

1.25

BDX Investor Care

Dividend Yield

1.54%

Diluted EPS (TTM)

4.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202318.8B19.0B19.4B0
202218.7B18.7B18.9B18.7B
202118.9B19.6B19.4B18.8B
202017.4B16.9B17.1B18.2B
201917.0B17.1B17.3B17.4B
201813.5B14.7B16.0B17.1B
201712.3B12.2B12.1B12.3B
201612.2B12.3B12.5B12.4B
20158.5B9.4B10.3B11.2B
20148.2B8.3B8.4B8.5B
20137.8B7.9B8.1B8.2B
20127.6B7.7B7.7B7.8B
20117.2B7.3B7.6B7.6B
20107.2B7.2B7.1B7.1B
20096.9B6.9B7.0B7.1B
20086.6B6.7B6.9B6.9B
2007006.3B6.4B

Latest Insider Trading transactions for BDX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 28, 2023
byrd richard
sold
-514,141
238
-2,156
evp & president interventional
Nov 26, 2023
mocherla pavan kumar
acquired
-
-
751
evp & president greater asia
Nov 26, 2023
shan david
sold (taxes)
-
-
-149
evp and chief isc officer
Nov 26, 2023
quinn michelle
sold (taxes)
-
-
-440
evp and general counsel
Nov 26, 2023
mocherla pavan kumar
sold (taxes)
-
-
-64.00
evp & president greater asia
Nov 26, 2023
goette roland
sold (taxes)
-
-
-213
evp and president emea
Nov 26, 2023
byrd richard
acquired
-
-
4,341
evp & president interventional
Nov 26, 2023
delorefice christopher
sold (taxes)
-
-
-812
evp & chief financial officer
Nov 26, 2023
spoerel thomas j
sold (taxes)
-
-
-365
svpcontroller & chief acct off
Nov 26, 2023
hickey david
acquired
-
-
1,663
evp & president, life sciences

1–10 of 50

Which funds bought or sold BDX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
CITIGROUP INC
reduced
-4.06
-3,591,230
55,781,600
0.04%
Dec 06, 2023
Grant Street Asset Management, Inc.
reduced
-0.1
-5,749
258,785
0.10%
Dec 06, 2023
VisionPoint Advisory Group, LLC
unchanged
-
-186
8,790
-%
Dec 06, 2023
Fragasso Group Inc.
reduced
-3.69
-32,232
532,726
0.06%
Dec 04, 2023
TUCKER ASSET MANAGEMENT LLC
unchanged
-
-510
24,043
0.01%
Dec 04, 2023
Phoenix Holdings Ltd.
new
-
1,415,320
1,415,320
0.01%
Dec 04, 2023
Trust Co
reduced
-59.18
-7,765
5,171
-%
Dec 01, 2023
PFS Partners, LLC
unchanged
-
-271
15,379
0.01%
Dec 01, 2023
B. Riley Wealth Advisors, Inc.
reduced
-65.83
-4,375,490
2,200,400
0.06%
Dec 01, 2023
Fortis Group Advisors, LLC
added
0.36
-30,162
482,296
0.15%

1–10 of 45

Latest Funds Activity

Are funds buying BDX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own BDX
No. of Funds

Schedule 13G FIlings of Becton Dickinson and Co

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
price t rowe associates inc /md/
6.7%
18,962,386
SC 13G/A
Feb 09, 2023
vanguard group inc
8.94%
25,421,347
SC 13G/A
Feb 07, 2023
blackrock inc.
8.4%
23,781,609
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
7.0%
20,016,331
SC 13G
Feb 09, 2022
vanguard group inc
8.48%
24,176,366
SC 13G/A
Feb 08, 2022
blackrock inc.
7.5%
21,348,508
SC 13G/A
Feb 16, 2021
price t rowe associates inc /md/
4.2%
12,347,992
SC 13G/A
Feb 10, 2021
vanguard group inc
8.38%
24,360,444
SC 13G/A
Feb 08, 2021
fmr llc
-
0
SC 13G/A
Feb 05, 2021
blackrock inc.
7.9%
22,926,497
SC 13G/A

Recent SEC filings of Becton Dickinson and Co

View All Filings
Date Filed Form Type Document
Nov 29, 2023
4
Insider Trading
Nov 28, 2023
144
Notice of Insider Sale Intent
Nov 28, 2023
4
Insider Trading
Nov 28, 2023
4
Insider Trading
Nov 28, 2023
4
Insider Trading
Nov 28, 2023
4
Insider Trading
Nov 28, 2023
4
Insider Trading
Nov 28, 2023
4
Insider Trading
Nov 28, 2023
4
Insider Trading
Nov 28, 2023
4
Insider Trading

Peers (Alternatives to Becton Dickinson and Co)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
181.1B
40.0B
9.79% -0.70%
35.09
4.53
-11.26% -34.57%
71.3B
19.4B
-8.82% -4.53%
44.09
3.79
2.66% -16.58%
18.5B
15.0B
6.81% -29.70%
7.13
1.23
3.01% 209.09%
16.6B
3.8B
9.66% 15.63%
45.73
4.36
-1.48% -28.97%
MID-CAP
9.3B
12.7B
13.63% -12.11%
20.89
0.73
0.68% -30.25%
9.0B
2.7B
2.35% -23.26%
-56.61
3.32
-3.01% 97.36%
8.3B
3.4B
1.55% 18.98%
29.56
2.41
3.13% 18.17%
6.9B
3.9B
14.40% 9.17%
-31.57
1.75
-2.62% 73.28%
2.9B
342.6M
8.31% -12.22%
-244.83
8.56
42.19% 84.14%
2.5B
6.6B
-12.97% -7.64%
12.41
0.38
2.61% 0.62%
SMALL-CAP
1.1B
3.1B
3.77% -63.31%
-2.53
0.35
7.95% -550.16%
329.0M
163.3M
7.10% -27.48%
-13.39
2.01
7.14% -56.09%
282.7M
335.9M
6.52% -42.04%
43.86
0.84
4.71% 116.39%
72.1M
50.3M
-18.43% 13.66%
-4.75
1.43
3.23% 20.81%
5.2M
3.8M
8.25% -44.93%
-0.45
1.37
17.30% 10.67%

Becton Dickinson and Co News

Latest updates
Nasdaq08 Dec 202309:00 pm62 minutes ago
InvestorsObserver21 Nov 202308:00 am17 days ago
Best Stocks13 Nov 202309:37 pm25 days ago
Smartkarma09 Nov 202308:00 am29 days ago
Mass Device02 Nov 202307:00 am36 days ago
Yahoo Finance23 Oct 202307:00 am46 days ago
The Market Periodical18 Oct 202307:00 am51 days ago
CNBC20 Sep 202307:00 am2 months ago
CNBC08 Aug 202307:00 am4 months ago
Yahoo Finance03 Aug 202307:00 am4 months ago
Mass Device01 Aug 202307:00 am4 months ago
Reuters25 Jul 202307:00 am4 months ago
Mass Device25 Jul 202307:00 am4 months ago
Yahoo Finance24 Jul 202307:00 am4 months ago
Yahoo Finance24 Jul 202307:00 am4 months ago

Financials for Becton Dickinson and Co

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue4.3%5,0874,8784,8214,5864,7614,6414,7504,7184,5764,6074,9075,3154,7843,8554,2534,2254,5844,3504,1954,1604,402
Costs and Expenses9.4%4,7384,3294,1934,0014,2724,1044,1854,0274,3454,1144,4734,0744,0573,4973,8843,7244,4743,7254,0593,2733,827
  S&GA Expenses-4.4%1,1381,1901,2051,1871,1831,1491,1921,1851,2541,2001,1481,1491,0599801,0251,1211,0941,0761,0891,0731,101
  R&D Expenses-8.2%281306337313300315327314355330317291243262264270270282252258277
EBITDA Margin-100.0%-0.24*0.24*0.23*0.23*0.25*0.24*0.24*0.25*0.24*0.24*0.24*0.21*0.21*0.22*0.21*0.24*0.27*0.28*0.28*-
Interest Expenses-5.0%11311911810210499.0097.0098.00112115124118123135134136141156171171181
Income Taxes-56.2%28.0064.0068.00-28.0033.0031.0052.0032.00-24.00-28.006.00154-34.00-38.0017.00117-1649.00-17.00115550
Earnings Before Taxes-61.6%1814715294813204214426002.003783051,157-428248200394-1.504603.00714415
EBT Margin-100.0%-0.09*0.09*0.09*0.09*0.11*0.11*0.10*0.11*0.10*0.10*0.10*0.06*0.05*0.06*0.05*0.07*0.09*0.10*0.10*-
Net Income-73.5%1084074605092883604546772655252991,00312828618327816345120.00599-135
Net Income Margin-100.0%-0.09*0.09*0.09*0.09*0.09*0.09*0.09*0.10*0.10*0.09*0.09*0.05*0.05*0.06*0.05*0.07*0.05*0.06*0.06*-
Free Cashflow-100.0%-8904.001916581372174864627329351,2871,2686602615401,01369558778.00-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-0.4%52,78053,01754,39453,12952,93453,19954,78653,36353,86654,33354,92154,74854,01253,95953,51651,95251,76552,23352,59852,93253,904
  Current Assets1.0%8,6768,5889,5878,1758,1419,54710,1528,3078,8389,53810,0009,5378,9698,8278,5556,4386,6646,7816,8446,9417,411
    Cash Equivalents60.5%1,4819231,9816121,0062,7593,3202,0472,3923,2823,8983,4472,9172,9642,4396095905947671,0421,236
  Inventory-8.8%3,2733,5883,6563,6043,2243,1633,2583,0352,7432,9472,8952,8142,7432,9452,7932,7602,5792,6292,6272,5222,451
  Net PPE1.3%6,5576,4746,3566,2476,0126,0056,4066,3846,0036,1646,1426,0965,9235,8415,6645,7825,6595,5505,4735,3625,375
  Goodwill-0.3%24,52224,58424,78024,76324,62123,96824,09624,11623,88623,81423,77223,75823,60423,54923,41523,43523,37623,49823,51323,50523,600
  Current Liabilities-3.4%6,6416,8787,3047,6257,8117,0806,6576,7356,6267,7495,3767,0215,8366,0678,7556,7265,6556,2377,1087,1457,216
    LT Debt, Non Current-1.3%14,73814,92616,01014,26813,88614,68317,58416,36017,11015,70017,71816,08217,22417,09016,80916,94918,08118,01617,55617,81718,894
Shareholder's Equity-0.5%25,79625,93725,68925,47225,28225,49324,52524,16023,67724,13524,82624,66323,76524,02220,95121,20221,08121,49721,30921,40420,994
  Retained Earnings-1.0%15,53515,69115,56315,38415,15715,08814,41614,23313,82613,82113,55713,52212,79112,91612,86812,93812,91312,99712,79213,01812,596
  Additional Paid-In Capital0.2%19,72019,68119,63919,59019,55319,51119,49519,43519,27219,28219,34119,30119,27019,22816,28816,32016,27016,22716,17716,17416,179
Accumulated Depreciation0.3%7,0217,0026,8486,6796,4026,3996,7886,6486,0906,4876,2776,1775,9965,8195,5985,6435,4695,4915,4025,2235,111
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations22.6%1,325,000,0001,081,000,000185,000,000399,000,000973,000,000678,000,000290,000,000530,000,000841,000,000564,000,0001,188,000,0001,533,000,000879,000,000862,000,000483,000,000713,000,0001,371,000,000932,000,000782,000,000245,000,0001,306,000,000
  Share Based Compensation3.6%58,000,00056,000,00056,000,00089,000,00049,000,00050,000,00053,000,00081,000,00047,000,00044,000,00055,000,00083,000,00043,000,00052,000,00059,000,00082,000,00053,000,00056,000,00059,000,00093,000,00061,000,000
Cashflow From Investing141.6%137,000,000-329,000,000-233,000,000-291,000,000-2,005,000,000-236,000,000-297,000,000-682,000,000-681,000,000-299,000,000-433,000,000-430,000,000-285,000,000-363,000,000-255,000,000-287,000,000-441,000,000-330,000,000-269,000,000299,000,000-560,000,000
Cashflow From Financing44.4%-997,000,000-1,794,000,0001,369,000,000-534,000,000-549,000,000-846,000,000986,000,000-327,000,000-1,142,000,000-1,271,000,000-301,000,000-592,000,000-1,208,000,00020,000,0001,623,000,000-413,000,000-923,000,000-768,000,000-798,000,000-734,000,000-1,007,000,000
  Dividend Payments-100.0%-286,000,000282,000,000281,000,000270,000,000271,000,000270,000,000271,000,000259,000,000261,000,000264,000,000264,000,000253,000,000268,000,000253,000,000252,000,000247,000,000246,000,000246,000,000245,000,000240,000,000
  Buy Backs-----500,000,000---750,000,000------------

BDX Income Statement

2023-09-30
Consolidated Statements of Income - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]   
Revenues$ 19,372$ 18,870$ 19,131
Cost of products sold11,20210,39310,500
Selling and administrative expense4,7194,7094,719
Research and development expense1,2371,2561,279
Acquisition-related integration and restructuring expense313192179
Other operating (income) expense, net(210)37203
Total Operating Costs and Expenses17,26116,58816,881
Operating Income2,1112,2822,250
Interest expense(452)(398)(469)
Interest income49169
Other expense, net(46)(117)(99)
Income from Continuing Operations Before Income Taxes1,6621,7831,692
Income tax provision13214888
Net Income from Continuing Operations1,5301,6351,604
(Loss) Income from Discontinued Operations, Net of Tax(46)144488
Net Income1,4841,7792,092
Preferred stock dividends(60)(90)(90)
Net income applicable to common shareholders$ 1,424$ 1,689$ 2,002
Basic Earnings per Share   
Income (Loss) from Continuing Operations, Per Basic Share$ 5.14$ 5.42$ 5.23
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share(0.16)0.501.69
Earnings Per Share, Basic4.975.936.92
Diluted Earnings per Share   
Income (Loss) from Continuing Operations, Per Diluted Share5.105.385.18
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share(0.16)0.501.67
Diluted Earnings per Share (USD per share)$ 4.94$ 5.88$ 6.85

BDX Balance Sheet

2023-09-30
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Sep. 30, 2022
Current Assets  
Cash and equivalents$ 1,416$ 1,006
Restricted cash65153
Short-term investments88
Trade receivables, net2,5342,191
Inventories3,2733,224
Prepaid expenses and other1,3801,559
Total Current Assets8,6768,141
Property, Plant and Equipment, Net6,5576,012
Goodwill24,52224,621
Developed Technology, Net8,0589,108
Customer Relationships, Net2,3382,683
Other Intangibles, Net552519
Other Assets2,0781,848
Total Assets52,78052,934
Current Liabilities  
Current debt obligations1,1412,179
Accounts payable1,6411,699
Accrued expenses2,6042,605
Salaries, wages and related items1,1151,171
Income taxes139157
Total Current Liabilities6,6417,811
Long-Term Debt14,73813,886
Long-Term Employee Benefit Obligations1,023902
Deferred Income Taxes and Other Liabilities4,5825,052
Commitments and Contingencies
Shareholders’ Equity  
Preferred Stock, Value, Issued02
Common Stock, Value, Issued371365
Capital in excess of par value19,72019,553
Retained earnings15,53515,157
Deferred compensation2423
Treasury Stock, Value(8,305)(8,330)
Accumulated other comprehensive loss(1,548)(1,488)
Total Shareholders’ Equity25,79625,282
Total Liabilities and Shareholders’ Equity$ 52,780$ 52,934
BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
 CEO
 WEBSITEwww.bd.com
 EMPLOYEES65535

Becton Dickinson and Co Frequently Asked Questions


What is the ticker symbol for Becton Dickinson and Co? What does BDX stand for in stocks?

BDX is the stock ticker symbol of Becton Dickinson and Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Becton Dickinson and Co (BDX)?

As of Thu Dec 07 2023, market cap of Becton Dickinson and Co is 71.29 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BDX stock?

You can check BDX's fair value in chart. The fair value of Becton Dickinson and Co is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Becton Dickinson and Co is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BDX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Becton Dickinson and Co a good stock to buy?

The fair value guage provides a quick view whether BDX is over valued or under valued. Whether Becton Dickinson and Co is cheap or expensive depends on the assumptions which impact Becton Dickinson and Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BDX.

What is Becton Dickinson and Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, BDX's PE ratio (Price to Earnings) is 44.09 and Price to Sales (PS) ratio is 3.79. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BDX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Becton Dickinson and Co's stock?

In the past 10 years, Becton Dickinson and Co has provided 0.097 (multiply by 100 for percentage) rate of return.